China Opens Printing, Chinese Medicine Industries to Foreign Investment
Listen to the full version

China has shortened its list of industries in which foreign businesses are either restricted or prohibited from investing, fulfilling a pledge to eliminate all limits on foreign investment in manufacturing, as policymakers attempt to revive inbound investment.
The update to the negative list, released Sunday by the Ministry of Commerce and the National Development and Reform Commission (NDRC), removed the requirement that publication-printing enterprises be domestically controlled. It also scrapped the ban on investing in the processing and production of certain traditional Chinese medicines.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- DIGEST HUB
- China removed restrictions on foreign investment in manufacturing, including publication-printing and certain traditional Chinese medicines, to boost inbound investment.
- This follows record-high FDI withdrawals in Q2 2023 and a 23-year low in net FDI inflows for the year, prompting efforts to revitalize the economy.
- Despite government initiatives to attract foreign investment, including opening up the service sector and providing support measures, concrete actions and local implementation are crucial to restore business confidence.
- PODCAST
- MOST POPULAR